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Abstract
Mycophenolic  acid (MPA) is a potent immunosuppressant agent, which is increasingly being used in the treatment
of patients with various autoimmune diseases. Dosing to achieve a specific target MPA area under the concentration-
time curve from 0 to 12 h post-dose (AUC ) is likely to  lead to better treatment outcomes in patients with 
autoimmune disease than a standard fixed-dose strategy. This review summarizes the available published data
around concentration monitoring strategies  for MPA in patients with autoimmune disease and examines the
accuracy and precision of methods reported to date using limited concentration-time points to estimate MPA AUC
. A total of 13 studies were identified that assessed the correlation between single time points and MPA AUC
and/or examined the predictive performance of limited sampling strategies  in estimating MPA AUC . The majority
of studies investigated mycophenolate mofetil (MMF) rather than the enteric-coated mycophenolate sodium (EC-MPS)
formulation of MPA. Correlations between MPA trough concentrations and MPA AUC  estimated by full
concentration-time profiling ranged from 0.13 to 0.94 across ten studies, with the highest associations (r  = 0.90-
0.94) observed in lupus nephritis patients. Correlations were generally higher in autoimmune disease patients
compared with renal allograft recipients and higher after MMF compared with EC-MPS intake. Four studies
investigated use of a limited sampling strategy to predict MPA AUC  determined by full concentration-time
profiling. Three studies used a limited sampling strategy consisting of a maximum combination of three sampling
time points with the latest sample drawn 3-6 h after MMF intake, whereas the remaining study tested all
combinations of sampling times. MPA AUC  was best predicted when three samples were taken at pre-dose and at 1
and 3 h post-dose with a mean bias and imprecision of 0.8 and 22.6 % for multiple linear regression analysis and of
-5.5 and 23.0 % for maximum a posteriori (MAP) Bayesian analysis. Although mean bias was less when data were
analysed using multiple linear regression, MAP Bayesian analysis is preferable because of its flexibility with respect to
sample timing. Estimation of MPA AUC  following EC-MPS administration using a limited sampling strategy with
samples drawn within 3 h post-dose resulted in biased and imprecise results, likely due to a longer time to reach a
peak MPA concentration (t ) with this formulation and more variable pharmacokinetic profiles. Inclusion of later 
sampling time points that capture enterohepatic recirculation and t  improved the predictive performance of 
strategies  to predict EC-MPS exposure. Given the considerable pharmacokinetic variability associated with
mycophenolate therapy, limited sampling strategies  may potentially help in individualizing patient dosing. However,
a compromise needs to be made between the predictive performance of the strategy and its clinical feasibility. An
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